Medtronic Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 7.2% to $3.12B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $3.26B to $3.12B.
Changes in this bucket reflect shifts in the company's duration management and medium-term reinvestment strategy.
This represents the amortized cost of debt securities in the available-for-sale portfolio that have maturity dates betwe...
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_2b276a| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $3.43B | $3.32B | $3.26B | $3.04B | $2.91B | $3.12B |
| QoQ Change | — | -3.2% | -2.0% | -6.8% | -4.2% | +7.2% |
| YoY Change | — | — | — | -11.5% | -12.5% | -4.3% |